Applying Reverse Genetics to Study Measles Virus Interactions with the Host.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2024
Historique:
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: ppublish

Résumé

The study of virus-host interactions is essential to achieve a comprehensive understanding of the viral replication process. The commonly used methods are yeast two-hybrid approach and transient expression of a single tagged viral protein in host cells followed by affinity purification of interacting cellular proteins and mass spectrometry analysis (AP-MS). However, by these approaches, virus-host protein-protein interactions are detected in the absence of a real infection, not always correctly compartmentalized, and for the yeast two-hybrid approach performed in a heterologous system. Thus, some of the detected protein-protein interactions may be artificial. Here we describe a new strategy based on recombinant viruses expressing tagged viral proteins to capture both direct and indirect protein partners during the infection (AP-MS in viral context). This way, virus-host protein-protein interacting co-complexes can be purified directly from infected cells for further characterization.

Identifiants

pubmed: 38743364
doi: 10.1007/978-1-0716-3870-5_7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-103

Informations de copyright

© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73(11):9679–9682. https://doi.org/10.1128/jvi.73.11.9679-9682.1999
doi: 10.1128/jvi.73.11.9679-9682.1999 pubmed: 10516084 pmcid: 113010
Nakaya T, Cros J, Park MS, Nakaya Y, Zheng HY, Sagrera A, Villar E, Garcia-Sastre A, Palese P (2001) Recombinant Newcastle disease virus as a vaccine vector. J Virol 75(23):11868–11873. https://doi.org/10.1128/jvi.75.23.11868-11873.2001
doi: 10.1128/jvi.75.23.11868-11873.2001 pubmed: 11689668 pmcid: 114773
Yun SI, Kim SY, Rice CM, Lee YM (2003) Development and application of a reverse genetics system for Japanese encephalitis virus. J Virol 77(11):6450–6465. https://doi.org/10.1128/jvi.77.11.6450-6465.2003
doi: 10.1128/jvi.77.11.6450-6465.2003 pubmed: 12743302 pmcid: 154991
Billeter MA, Naim HY, Udem SA (2009) Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr Top Microbiol Immunol 329:129–162. https://doi.org/10.1007/978-3-540-70523-9_7
doi: 10.1007/978-3-540-70523-9_7 pubmed: 19198565 pmcid: 7120638
Isel C, Munier S, Naffakh N (2016) Experimental approaches to study genome packaging of influenza A viruses. Viruses 8(8):218. https://doi.org/10.3390/v8080218
doi: 10.3390/v8080218 pubmed: 27517951 pmcid: 4997580
Neumann G, Kawaoka Y (2001) Reverse genetics of influenza virus. Virology 287(2):243–250. https://doi.org/10.1006/viro.2001.1008
doi: 10.1006/viro.2001.1008 pubmed: 11531402
Stobart CC, Moore ML (2014) RNA virus reverse genetics and vaccine design. Viruses 6(7):2531–2550. https://doi.org/10.3390/v6072531
doi: 10.3390/v6072531 pubmed: 24967693 pmcid: 4113782
Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dotsch C, Christiansen G, Billeter MA (1995) Rescue of measles viruses from cloned DNA. EMBO J 14(23):5773–5784. https://doi.org/10.1002/j.1460-2075.1995.tb00266.x
doi: 10.1002/j.1460-2075.1995.tb00266.x pubmed: 8846771 pmcid: 394696
Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F (2003) A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol 77(21):11546–11554. https://doi.org/10.1128/jvi.77.21.11546-11554.2003
doi: 10.1128/jvi.77.21.11546-11554.2003 pubmed: 14557640 pmcid: 229349
Mahmoudi Gomari M, Saraygord-Afshari N, Farsimadan M, Rostami N, Aghamiri S, Farajollahi MM (2020) Opportunities and challenges of the tag-assisted protein purification techniques: applications in the pharmaceutical industry. Biotechnol Adv 45:107653. https://doi.org/10.1016/j.biotechadv.2020.107653
doi: 10.1016/j.biotechadv.2020.107653 pubmed: 33157154
Ohashi M, Holthaus AM, Calderwood MA, Lai C-Y, Krastins B, Sarracino D, Johannsen E (2015) The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. PLoS Pathog 11(4):e1004822. https://doi.org/10.1371/journal.ppat.1004822
doi: 10.1371/journal.ppat.1004822 pubmed: 25855980 pmcid: 4391933
Fan J, Xiao P, Kong D, Liu X, Meng L, An T, Cai X, Wang H, Yu L (2022) Engineering His-tagged Senecavirus A for one-step purification of viral antigens. Vaccines (Basel) 10(2):170. https://doi.org/10.3390/vaccines10020170
doi: 10.3390/vaccines10020170 pubmed: 35214628
Ma X, Li C, Xia Q, Zhang Y, Yang Y, Wahaab A, Liu K, Li Z, Li B, Qiu Y, Wei J, Ma Z (2022) Construction of a recombinant Japanese encephalitis virus with a hemagglutinin-tagged NS2A: a model for an analysis of biological characteristics and functions of NS2A during viral infection. Viruses 14(4):706. https://doi.org/10.3390/v14040706
doi: 10.3390/v14040706 pubmed: 35458436 pmcid: 9024733
Skerra A, Schmidt TGM (1999) Applications of a peptide ligand for streptavidin: the Strep-tag. Biomol Eng 16(1–4):79–86. https://doi.org/10.1016/s1050-3862(99)00033-9
doi: 10.1016/s1050-3862(99)00033-9 pubmed: 10796988
Mayer D, Molawi K, Martinez-Sobrido L, Ghanem A, Thomas S, Baginsky S, Grossmann J, Garcia-Sastre A, Schwemmle M (2007) Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res 6(2):672–682. https://doi.org/10.1021/pr060432u
doi: 10.1021/pr060432u pubmed: 17269724 pmcid: 2577182
De Maio FA, Risso G, Iglesias NG, Shah P, Pozzi B, Gebhard LG, Mammi P, Mancini E, Yanovsky MJ, Andino R, Krogan N, Srebrow A, Gamarnik AV (2016) The dengue virus NS5 protein intrudes in the cellular spliceosome and modulates splicing. PLoS Pathog 12(8):e1005841. https://doi.org/10.1371/journal.ppat.1005841
doi: 10.1371/journal.ppat.1005841 pubmed: 27575636 pmcid: 5004807
Fournier G, Chiang C, Munier S, Tomoiu A, Demeret C, Vidalain PO, Jacob Y, Naffakh N (2014) Recruitment of RED-SMU1 complex by Influenza A virus RNA polymerase to control viral mRNA splicing. PLoS Pathog 10(6):e1004164. https://doi.org/10.1371/journal.ppat.1004164
doi: 10.1371/journal.ppat.1004164 pubmed: 24945353 pmcid: 4055741
Li Y, Frederick KM, Haverland NA, Ciborowski P, Belshan M (2016) Investigation of the HIV-1 matrix interactome during virus replication. Proteomics Clin Appl 10(2):156–163. https://doi.org/10.1002/prca.201400189
doi: 10.1002/prca.201400189 pubmed: 26360636
Komarova AV, Combredet C, Meyniel-Schicklin L, Chapelle M, Caignard G, Camadro JM, Lotteau V, Vidalain PO, Tangy F (2011) Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses. Mol Cell Proteomics 10(12):M110.007443. https://doi.org/10.1074/mcp.M110.007443
doi: 10.1074/mcp.M110.007443 pubmed: 21911578 pmcid: 3237069
Meignie A, Combredet C, Santolini M, Kovacs IA, Douche T, Gianetto QG, Eun H, Matondo M, Jacob Y, Grailhe R, Tangy F, Komarova AV (2021) Proteomic analysis uncovers measles virus protein C interaction with p65-iASPP protein complex. Mol Cell Proteomics 20:100049. https://doi.org/10.1016/j.mcpro.2021.100049
doi: 10.1016/j.mcpro.2021.100049 pubmed: 33515806 pmcid: 7950213
Komarova AV, Combredet C, Sismeiro O, Dillies MA, Jagla B, Sanchez David RY, Vabret N, Coppee JY, Vidalain PO, Tangy F (2013) Identification of RNA partners of viral proteins in infected cells. RNA Biol 10(6):944–956. https://doi.org/10.4161/rna.24453
doi: 10.4161/rna.24453 pubmed: 23595062
Iverson LE, Rose JK (1981) Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 23(2):477–484. https://doi.org/10.1016/0092-8674(81)90143-4
doi: 10.1016/0092-8674(81)90143-4 pubmed: 6258804
Muhlberger E (2007) Filovirus replication and transcription. Future Virol 2(2):205–215. https://doi.org/10.2217/17460794.2.2.205
doi: 10.2217/17460794.2.2.205 pubmed: 24093048 pmcid: 3787895
Cattaneo R, Rebmann G, Schmid A, Baczko K, ter Meulen V, Billeter MA (1987) Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 6(3):681–688. https://doi.org/10.1002/j.1460-2075.1987.tb04808.x
doi: 10.1002/j.1460-2075.1987.tb04808.x pubmed: 3582370 pmcid: 553451
Plumet S, Duprex WP, Gerlier D (2005) Dynamics of viral RNA synthesis during measles virus infection. J Virol 79(11):6900–6908. https://doi.org/10.1128/JVI.79.11.6900-6908.2005
doi: 10.1128/JVI.79.11.6900-6908.2005 pubmed: 15890929 pmcid: 1112129

Auteurs

Heidy Vera-Peralta (H)

Institut Pasteur, Université Paris Cité, Innovation Lab: Vaccines, Paris, France.
Institut de recherche biomédicale des armées, Immunopathologie, Bretigny-sur-Orge, France.

Valerie Najburg (V)

Institut Pasteur, Université Paris Cité, Innovation Lab: Vaccines, Paris, France.

Chantal Combredet (C)

Institut Pasteur, Université Paris Cité, Innovation Lab: Vaccines, Paris, France.

Thibaut Douché (T)

Institut Pasteur, Université Paris Cité, Proteomics Platform, Mass Spectrometry for Biology, CNRS, Paris, France.

Quentin Giai Gianetto (QG)

Institut Pasteur, Université Paris Cité, Proteomics Platform, Mass Spectrometry for Biology, CNRS, Paris, France.
Institut Pasteur, Université Paris Cité, Bioinformatics Hub, Paris, France.

Mariette Matondo (M)

Institut Pasteur, Université Paris Cité, Proteomics Platform, Mass Spectrometry for Biology, CNRS, Paris, France.

Frédéric Tangy (F)

Oncovita, Paris, France.

Marie Mura (M)

Institut Pasteur, Université Paris Cité, Innovation Lab: Vaccines, Paris, France.
Institut de recherche biomédicale des armées, Immunopathologie, Bretigny-sur-Orge, France.

Anastassia V Komarova (AV)

Institut Pasteur, Université Paris Cité, Interactomics, RNA and Immunity Laboratory, Paris, France. anastasia.komarova@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH